What You Should Know:
- Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson’s disease, according to a recent research study.
- The study, conducted in collaboration with Michael J. Fox Foundation, identified that PreciseDx’s technology can accurately diagnose Parkinson's disease in living patients prior to the severe onset of symptoms.
Challenges Diagnosing Parkinson’s
Read More
Michael J. Fox Foundation
Alphabet and Michael J. Fox Foundation Team Up to Use Verily Study Watch to Research Parkinson’s Disease
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Verily Life Sciences LLC, an Alphabet company has announced a new collaboration on a two-year sub-study in Parkinson's Progression Markers Initiative will include Verily Study Watch to add new dimension of health data. More than 800 participants will be equipped with Verily's multi-sensor investigational wearable device, to passively collect data on movement and physiologic and environmental measures continuously. The goal is to
Read More
New Scripps Study Combines DNA Testing, Sensors to Improve Parkinson’s Diagnosis
Researchers at the Scripps Translational Science Institute (STSI) have launched a new study that aims to improve screening accuracy for Parkinson’s disease by combining the power of genetic sequencing and wireless sensors. Researchers hope to validate a testing method that can accurately differentiate between Parkinson’s disease and essential tremor, the most common movement disorder, which is often mistaken for Parkinson’s. Earlier and better diagnosis could improve the use of treatment options
Read More
